Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia

被引：0
|
作者：
Farnier, M. [1 ]
Guyton, J. R. [2 ]
Jensen, E. [3 ]
Polis, A. [3 ]
Johnson-Levonas, A. O. [3 ]
Brudi, P. [3 ]
机构：
[1] Point Med, Dijon, France
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
[3] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [41] Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
    Ruel, Isabelle
    Aljenedil, Sumayah
    Sadri, Iman
    de Varennes, Emilie
    Hegele, Robert A.
    Couture, Patrick
    Bergeron, Jean
    Wanneh, Eric
    Baass, Alexis
    Dufour, Robert
    Gaudet, Daniel
    Brisson, Diane
    Brunham, Liam R.
    Francis, Gordon A.
    Cermakova, Lubomira
    Brophy, James M.
    Ryomoto, Arnold
    Mancini, G. B. John
    Genest, Jacques
    CLINICAL CHEMISTRY, 2018, 64 (02) : 355 - 362
  • [42] NON-HDL CHOLESTEROL/APOLIPOPROTEIN B RATIO IN THE DIAGNOSIS OF DYSBETALIPOPROTEINEMIA
    Bea, A. M.
    Cenarro, A.
    Marco, V.
    Mateo-Gallego, R.
    Jarauta, E.
    Gracia-Rubio, I.
    Laclaustra, M.
    Civeira, F.
    ATHEROSCLEROSIS, 2021, 331 : E214 - E214
  • [43] Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
    Knopp, RH
    Gitter, H
    Truitt, T
    Bays, H
    Manion, CV
    Lipka, LJ
    LeBeaut, AP
    Suresh, R
    Yang, B
    Veltri, EP
    EUROPEAN HEART JOURNAL, 2003, 24 (08) : 729 - 741
  • [44] Ezetimibe plus simvastatin treatment reduces chylomicron-cholesterol but not retinyl esters in primary hypercholesterolemics
    Quintao, ECR
    Nunes, VS
    Neves, MQT
    Katona, KN
    Nakandakare, ER
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 118 - 118
  • [45] BASELINE CHOLESTEROL ABSORPTION MARKERS DO NOT PREDICT LDL-CHOLESTEROL REDUCTION BY EZETIMIBE/SIMVASTATIN IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST-HOC ANALYSIS OF THE ENHANCE TRIAL
    Jakulj, L.
    Vissers, M.
    Hutten, B.
    Groen, A.
    Lutjohann, D.
    Veltri, E.
    Kastelein, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [46] Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe
    Rudofsky, Gottfried
    Reismann, Peter
    Groener, Jan B.
    Djuric, Zdenka
    Fleming, Thomas
    Metzner, Cornelia
    Grafe, Ingo A.
    Bierhaus, Angelika
    Nawroth, Peter P.
    ATHEROSCLEROSIS, 2012, 223 (01) : 190 - 196
  • [47] Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol
    Contois, John H.
    Langlois, Michel R.
    Cobbaert, Christa
    Sniderman, Allan D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (15):
  • [48] Differential effects of simvastatin and atorvastatin on HDL-cholesterol and apolipoprotein A-I
    Pauciullo, P
    Liu, M
    Capece, R
    Mercuri, M
    ATHEROSCLEROSIS, 1999, 146 : S27 - S28
  • [49] Reaching target LDL cholesterol has become more affordable with launch of ezetimibe/simvastatin combination in South Africa
    Aalbers, J.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2010, 21 (05) : 291 - 291
  • [50] Effects of ezetimibe/simvastatin compared to simvastatin monotherapy in reducing C-reactive protein and low density lipoprotein-cholesterol
    Ballantyne, CM
    Ridker, P
    Pearson, T
    Veltri, E
    Mitchel, YB
    Sisk, CMM
    Shah, AK
    Maccubbin, DL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 316A - 316A
12345